The Houston HIITBAC for African Americans

NCT02253433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2018-11-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to improve the health of African-American adults who have poorly controlled asthma. The study compares a home-based exposure reduction and asthma control intervention to enhanced in-clinic care that includes a standard clinical appointment as well as information from a detailed exposure history, asthma education, assessment for allergies, and a customized asthma self-management plan developed using motivational interviewing. The interventional group receives enhanced in-clinic care, as well as a customized home-based environmental exposure assessment and multicomponent exposure reduction and asthma control intervention (five home visits over approximately 12 months).

Conditions

Interventions

OTHER

Enhanced Clinic Care

The intervention includes a standard clinical appointment including spirometry, as well as collection of self-report information from detailed health and exposure questionnaires, asthma education, assessment for allergies, and a customized asthma self-management plan developed using motivational interviewing.

OTHER

Enhanced Clinic Care + Home Intervention

The home-based component includes environmental exposure assessment (observed and measured) and a multicomponent exposure reduction and asthma control intervention (five home visits over approximately 12 months).

Sponsors & Collaborators

  • Harris County Hospital District

    collaborator OTHER_GOV
  • Houston Department of Health and Human Services

    collaborator UNKNOWN
  • Texas A&M University

    collaborator OTHER
  • M.D. Anderson Cancer Center

    collaborator OTHER
  • UTHealth School of Public Health

    collaborator UNKNOWN
  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Winifred J Hamilton, PhD, SM · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-08
Primary Completion
2018-01-26
Completion
2018-01-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02253433 on ClinicalTrials.gov